Global Pharma Healthcare

Global Pharma Healthcare is an Indian pharmaceutical company based in Chennai that specializes in the manufacturing and export of a wide range of generic drug formulations. The company provides a diverse portfolio including sterile ophthalmic solutions, tablets, capsules, and liquid orals, serving both domestic and international markets. In 2023, the firm gained significant international attention following a major voluntary recall of its Artificial Tears eye drops, which were linked to a multi-state outbreak of drug-resistant bacteria in the United States. Operating primarily as a contract manufacturer, Global Pharma Healthcare serves various global distributors and maintains facilities designed for large-scale production of essential medicines. The company continues to navigate regulatory oversight from the FDA and Indian authorities following these safety concerns.